-->

Orion Nutraceuticals Clarifies Name Change Announcement



 

September 5, 2025 – TheNewswire - Vancouver, British Columbia - Orion Nutraceuticals Inc. (CSE:ORI) (the Company”) wishes to clarify its news release dated September 4, 2025 regarding the Company’s proposed name change and share consolidation.

 

The Company previously announced incorrectly that it would be changing its name to Pinetree Ventures Corp. The Company confirms that the new name will be Pinetown Ventures Corp. (the “Name Change”).

 

As disclosed, the Name Change will be effective on Tuesday, September 9, 2025, in conjunction with the previously announced share consolidation (the “Consolidation”). All other terms of the Consolidation remain unchanged as described in the Company’s September 4, 2025 news release.

 

The new CUSIP number for the common shares of the Company will be 723328209 and the new ISIN number will be CA7233282093.

 

On behalf of the Board of Directors of:

 

Orion Nutraceuticals Inc.

Guy Bourgeois, Director
Tel: (
604) 687-2038

 

Information set forth in this press release may involve forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company’s expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the need for additional financing; reliance on key personnel; and the potential for conflicts of interest among certain officers or directors with certain other projects. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and except as required by law, the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Investors are cautioned against attributing undue certainty to forward-looking statements. For further information on risk, investors are advised to see the Company’s MD&A and other disclosure filings with the regulators which are found at www.sedarplus.ca.